Paving the road to clinical trial participation-removing road blocks and directing patients toward novel therapies

od Wang-Gillam, Andrea, Williams, Kristina
izdano v J Natl Compr Canc Netw (2015)

Entering the molecular era of gastrointestinal oncology: current updates and challenges

od Wang-Gillam, Andrea, Lim, Kian-Huat
izdano v J Gastrointest Oncol (2017)

Promising therapeutics of gastrointestinal cancers in clinical trials

od Du, Lingling, Che, Zheng, Wang-Gillam, Andrea
izdano v J Gastrointest Oncol (2017)

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies

od Teague, Andrea, Lim, Kian-Huat, Wang-Gillam, Andrea
izdano v Ther Adv Med Oncol (2015)

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma

od So, Eiichiro, Crees, Zachary D., Crites, Danielle, Wang-Gillam, Andrea
izdano v J Pancreat Cancer (2017)

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

od Peddi, Parvin F., Cho, May, Wang, Jian, Gao, Feng, Wang-Gillam, Andrea
Izdano 2013

Targeting RAS-mutant cancers: is ERK the key?

od Ryan, Meagan B., Der, Channing J., Wang-Gillam, Andrea, Cox, Adrienne D.
izdano v Trends Cancer (2015)

Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization

od Atkins, Jordan J., Fiala, Mark A., Wang-Gillam, Andrea, Wildes, Tanya M.
izdano v Pancreas (2016)

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature

od How, Joan, Blattner, Margaret, Fowler, Susan, Wang-Gillam, Andrea, Schindler, Suzanne E
izdano v Neurologist (2016)

Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma

od Du, Lingling, DeFoe, Melissa, Ruzinova, Marianna B., Olsen, Jeffrey R., Wang-Gillam, Andrea
izdano v Hematol Oncol Clin North Am (2015)

Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?

od Lim, Kian-Huat, Chung, Eugene, Khan, Adeel, Cao, Dengfeng, Linehan, David, Ben-Josef, Edgar, Wang-Gillam, Andrea
Izdano 2012

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

od Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.
izdano v Invest New Drugs (2015)

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

od Cho, May, Peddi, Parvin F, Ding, Kevin, Chen, Ling, Thomas, Denise, Wang, Jian, Lockhart, Albert C, Tan, Benjamin, Wang-Gillam, Andrea
Izdano 2013

Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy

od Jiang, Hong, Knolhoff, Brett, Zhu, Yu, Herndon, John, Shapiro, Irina, Weaver, David, Pachter, Jonathan, Wang-Gillam, Andrea, DeNardo, David G
izdano v J Immunother Cancer (2015)

Immunogenicity of influenza vaccination in patients with cancer

od Waqar, Saiama N., Boehmer, Leigh, Morgensztern, Daniel, Wang-Gillam, Andrea, Sorscher, Steven, Lawrence, Steven, Gao, Feng, Guebert, Kalin, Williams, Kristina, Govindan, Ramaswamy
izdano v Am J Clin Oncol (2018)

Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models

od Jiang, Hongmei, Xu, Mai, Li, Lin, Grierson, Patrick, Dodhiawala, Paarth, Highkin, Maureen, Zhang, Daoxiang, Li, Qiong, Wang-Gillam, Andrea, Lim, Kian-Huat
izdano v Mol Cancer Ther (2018)

Tumor-Stroma IL-1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, And Poor Prognosis In Pancreatic Cancer

od Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Li, Qiong, Wang-Gillam, Andrea, Yu, Jinsheng, Head, Richard, Liu, Jingxia, Ruzinova, Marianna B., Lim, Kian-Huat
izdano v Cancer Res (2018)

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance In Pancreatic Ductal Adenocarcinoma

od Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Knolhoff, Brett, Lockhart, Albert C., Wang-Gillam, Andrea, DeNardo, David G., Ruzinova, Marianna B., Lim, Kian-Huat
izdano v Clin Cancer Res (2016)

Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer

od Amin, Manik, Desai, Monica, Trinkaus, Kathryn, Brown, Amberly, Wang-Gillam, Andrea, Tan, Benjamin, Picus, Joel, Sorscher, Steven, Highkin, Maureen, Lears, Kim, Lockhart, Albert C.
izdano v J Gastrointest Oncol (2019)

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

od Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig
Izdano 2011